Enzo Biochem Inc. (NYSE:ENZ)’s share price traded down 3.2% during trading on Friday . The stock traded as low as $5.65 and last traded at $5.66, with a volume of 81,788 shares traded. The stock had previously closed at $5.85.

Separately, Zacks Investment Research downgraded shares of Enzo Biochem from a “buy” rating to a “hold” rating in a research note on Tuesday, August 9th.

The stock has a market capitalization of $264.17 million and a price-to-earnings ratio of 14.95. The stock has a 50 day moving average of $6.28 and a 200-day moving average of $5.49.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Wednesday, June 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.02. During the same period in the prior year, the business earned ($0.07) EPS. The business had revenue of $18.16 million for the quarter, compared to analyst estimates of $24.50 million. Equities analysts anticipate that Enzo Biochem Inc. will post ($0.23) earnings per share for the current year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.